Clinical Trial Update: Comparison of Different Up-dosing Schedules With Osiris [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating different up-dosing schedules of Osiris for allergic rhinitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Osiris

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergic Rhinitis | Phase 2 | Status: TERMINATED